Navigation Links
Single-cell parasites co-opt 'ready-made' genes from host: UBC research
Date:7/18/2012

Two species of single-cell parasites have co-opted "ready-made" genes from their hosts that in turn help them exploit their hosts, according to a new study by University of British Columbia and University of Ottawa researchers.

Part of a group of parasitic microbes called microsporidia, Encephalitozoon hellem and Encephalitozoon romaleae are related to fungi and are commonly found in the intestines of vertebrates. In humans, they are associated with people with immune deficiencies.

The research team identified six genes in these parasites that were not found in any other microsporidian. Rather than the slow process of inheriting individual genes, E. hellem and E. romaleae have acquired a suite of genes that produce folate, a form of folic acid that helps cell division and growth.

"With their tiny, reduced genomes, microsporidia are models for gene loss," says lead author Patrick Keeling, a professor in UBC's Dept. of Botany.

"These parasites have undergone massive genome reductions and are literally infection machines they only kept genes that are essential for survival."

"But here we found two species have actually acquired new genes that work together to make an essential nutrient that the parasites would otherwise have to steal from their host opening up new tissues or even new hosts as targets for infection," says Keeling, director of the Centre for Microbial Diversity and Evolution and a member of Beaty Biodiversity Research Centre at UBC.

The process of horizontal gene transfer the ability to acquire ready-made genes with specific functions from foreign genomes is an important but often overlooked mechanism of evolution, according to Keeling. "It helps explain the relatively rapid evolution of these tiny organisms and their ability to infect and live off of a wide variety of hosts."


'/>"/>

Contact: Brian Lin
brian.lin@ubc.ca
60-048-222-234
University of British Columbia
Source:Eurekalert

Page: 1

Related biology news :

1. Nanobubbles plus chemotherapy equals single-cell cancer targeting
2. Elsevier launches International Journal for Parasitology: Parasites and Wildlife
3. T cells hunt parasites like animal predators seek prey, a Penn Vet-Penn Physics study reveals
4. Scientists find Achilles heel in life-threatening malaria parasites
5. Weakness can be an advantage in surviving deadly parasites, a new study shows
6. Exome sequencing of health condition extremes can reveal susceptibility genes
7. Genes may play role in educational achievement, study finds
8. World experts meet in Edinburgh to consider how life experiences impact on our genes
9. Parasitic plants steal genes from their hosts
10. Manipulating chromatin loops to regulate genes may offer future treatments for blood diseases
11. Its in the genes: Research pinpoints how plants know when to flower
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... -- BioCatch , the global leader in behavioral biometrics, ... grew to over 40 granted and pending patents. ... , , The Company,s IP ... System, Device, and Method Estimating Force Applied to a Touch Surface, ... costly hardware components needed to estimate the force and pressure applied to ...
(Date:12/7/2016)... 2016   Veridium , a leader in ... new CEO James Stickland . Stickland, a ... experience, has served in senior executive roles for ... in expanding a pipeline of venture capital and ... recently served as managing director of U.K.-based fintech ...
(Date:12/6/2016)... Valencell , the leading innovator in performance biometric ... consecutive year of triple digit growth for its PerformTek ... 360 percent increase in companies who have acquired Valencell ... sales of its wrist and ear Benchmark™ sensor systems, ... hearables for fitness and healthcare applications. ...
Breaking Biology News(10 mins):
(Date:12/9/2016)... 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... to announce that Biohaven has issued today the following ... (PRWEB) Dec 9, 2016 - Biohaven Pharmaceutical ... that the U.S. Food and Drug Administration ("FDA") has ... drug candidate BHV-0223, an orally dissolving tablet being developed ...
(Date:12/8/2016)... Dec. 8, 2016  OncoSec Medical Incorporated ("OncoSec") ... DNA-based intratumoral cancer immunotherapies, today announced financial results ... "We are delivering on our commitment to ... ImmunoPulse® IL-12. We are pleased with the early ... trial, and we are focused on advancing our ...
(Date:12/8/2016)... Eurofins announces the appointment of Sean Murray , ... Inc. (ESI). Mr. Murray will bring valuable expertise ... experience in leading international business teams. As the National Division Leader, ... uphold Eurofins, status as the global leader in bio-analytical testing services. ... , , ...
(Date:12/8/2016)... , Dec. 8, 2016  Anaconda BioMed S.L., ... development of the next generation neuro-thrombectomy system for the ... of Tudor G. Jovin, MD to join its Scientific ... as a strategic network of scientific and clinical experts ... development of the ANCD BRAIN ® to its ...
Breaking Biology Technology: